What Are The Chances Of Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. The stock was recently discussed on Yahoo Finance as it revealed that New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

As a NYSE listed company, TEVA falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Teva- Pharmaceutical Industries Ltd. ADR is $15.97B. A total of 9.24 million shares were traded on the day, compared to an average of 10.73M shares.

In the most recent transaction, Kalif Eliyahu Sharon sold 77,550 shares of TEVA for 13.52 per share on Mar 06 ’24. After the transaction, the EVP, Chief Financial Officer now owns 203,691 company shares. In a previous transaction on Mar 05 ’24, Sabag Mark sold 100,000 shares at 13.52 per share. TEVA shares that EVP, International Markets owns now total 382,590.

Among the insiders who sold shares, Daniell Richard disposed of 48,629 shares on Mar 05 ’24 at a per-share price of $13.52. This resulted in the Exec. VP, European Commercial holding 69,770 shares of TEVA after the transaction. In another insider transaction, Conway Vikki L sold 1,427 shares at $13.52 per share on Mar 05 ’24. Company shares held by the See “Remarks” now total 15,219.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, TEVA has a high of $14.45 and a low of $7.09.

As of this writing, TEVA has an earnings estimate of $0.52 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of $0.57 per share and a lower estimate of $0.47. The company reported an EPS of $0.6 in the last quarter, which was -1.60% lower than expectations of $0.61.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. TEVA’s latest balance sheet shows that the firm has $2.17B in Cash & Short Term Investments as of fiscal 2021. There were $23.46B in debt and $11.03B in liabilities at the time. Its Book Value Per Share was $6.70, while its Total Shareholder’s Equity was $11.24B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TEVA is Buy with a score of 4.33.

Most Popular

Related Posts